The biosimilar market in KSA is expanding and is expected to continue this trajectory in the coming decade. The growth of the market is influenced by the KSA health transformation initiative, the well-defined regulatory framework for biosimilars set by the Saudi Food and Drug Authority (SFDA), and the adoption of biosimilars by healthcare providers.
Related: Saudi Arabia marks healthcare transformation boom
Overall, biosimilar regulation is evolving, and the future of biosimilars looks promising in KSA. Biosimilars offer a more cost-effective alternative, which can help to expand access to more treatment options for patients and contribute to cost savings for the healthcare system.
Related: Advancements in CAR T-cell therapy and the need for strategic collaboration
A report by Taylor & Francis describes the current and future biosimilar landscape in KSA. It discusses the growth of the biosimilar market, the regulatory approval process, biosimilar adoption, and the potential impact on healthcare systems and patient outcomes.
Article highlights
- The healthcare transformation in KSA is a key driver to promote acceptability and adaptability to use biosimilars in clinical practice.
- Biosimilars are a promising strategy to reduce the increasing trend in pharmaceutical expenditure in KSA.
- The SFDA biosimilar regulations are aligned with those in highly regulated regions with approvals based on regulatory reliance and independent scientific assessment.
- There are 38 SFDA-approved biosimilars, with the number expected to rise in the near future to satisfy the high demand for cost-efficient therapies.
- Biosimilar regulation in KSA is evolving and maturing in the evaluation and monitoring of the safety, efficacy, and quality of products entering the market.
- The SFDA has created regulatory incentives to improve the accessibility and availability of affordable alternatives for cost-efficient therapies.
To learn more, download the report here
To learn more about the latest developments in Saudi Arabia's healthcare industry, attend the Global Health Exhibition taking place from 29-31 October at Riyadh Front Exhibition & Conference Center (RFECC). Click here to know more.
Also, join industry experts in learning more about the latest trends in Saudi Arabia's healthcare industry by registering for the webinar "How innovation and tech are fuelling investment in Saudi Arabia's healthcare market."
